| Name | Title | Contact Details |
|---|
Fresh Kitchen is a healthy fast-casual restaurant chain founded in 2014 and based in Boca Raton, Florida. The restaurant specializes in 100% gluten-free, customizable meals that cater to various dietary preferences, including vegan, keto, and carnivore diets. Their menu features high-quality, scratch-made recipes using fresh ingredients, antibiotic-free and hormone-free meats, homemade sauces, and hand-cut vegetables cooked in 100% olive oil. Customers can create their own balanced bowls by selecting from a variety of bases, freshly roasted vegetables, grilled or roasted meats, and flavorful toppings. Fresh Kitchen also offers daily in-house pressed juices, teas, and juice frescas, with seasonal recipes to ensure freshness. The company emphasizes fast service without compromising quality, aiming to support active lifestyles. In addition to their food offerings, Fresh Kitchen is dedicated to community impact and sustainability. They engage in local givebacks, food donations, and composting, supporting causes that align with their values. With around 64 employees and reported revenue of $31.2 million, Fresh Kitchen is recognized for combining convenience, quality, and social responsibility in the healthy fast food sector.
Honest1, a national full-service auto care company, is passionate about putting customers first. Its customer-centric, transparent approach assures every customer is thoroughly educated on the systems and services necessary to keep their vehicles in the best running condition. Honest1 centers are family-friendly with clean and upscale waiting areas, Internet cafes, childrens play areas, comfortable leather chairs and couches, HDTVs and complimentary beverage stations. In addition to putting its customers first, Honest1 Auto Care performs H-1 ESA Quality checks at each of its locations to ensure performance is environmentally sustainable.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
FM Global is a Rhode Island-based insurance company that specializes in property insurance, risk consulting and loss prevention for businesses.